LICENSE AND SUPPLY AGREEMENT by and among NOVARTIS, AG, NOVARTIS CONSUMER HEALTH, INC. and ENDO PHARMACEUTICALS INC. Dated as of March 4, 2008License and Supply Agreement • May 2nd, 2008 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations • New York
THIS LICENSE AND SUPPLY AGREEMENT (this “Agreement”), dated as of March 4, 2008 (the “Execution Date”), by and among NOVARTIS, AG, a Swiss corporation having a principal place of business in Basel, Switzerland (“NOVARTIS AG”), NOVARTIS CONSUMER HEALTH, INC., a Delaware corporation having a principal place of business at 200 Kimball Drive, Parsippany, New Jersey 07054 (“NOVARTIS,” and collectively with NOVARTIS AG, the “NOVARTIS Parties”) and ENDO PHARMACEUTICALS INC., a Delaware corporation having a principal place of business at 100 Endo Drive, Chadds Ford, Pennsylvania 19317 (“ENDO”). Each of NOVARTIS and ENDO is referred to herein individually as a “Party” and collectively as the “Parties.”
AMENDMENT NO. 1 TO LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • May 2nd, 2008 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations
This Amendment No. 1 to that certain License and Supply Agreement (this “Amendment”) is entered into as of March 28, 2008, by and among Novartis AG, Novartis Consumer Health, Inc. (collectively, “Novartis”) and Endo Pharmaceuticals Inc. (“Endo”).
FIRST AMENDMENT TO LEASELease • May 2nd, 2008 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations
THIS IS AN AMENDMENT (“Amendment”) made this 3rd day of March, 2008, between PAINTERS’ CROSSING THREE ASSOCIATES, L.P. (“Landlord”) and ENDO PHARMACEUTICALS INC. (“Tenant”).
